Raymond James Financial CapEx decreased by 2.2% to $45.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.2%, from $46.00M to $45.00M. Over 3 years (FY 2022 to FY 2025), CapEx shows an upward trend with a 27.4% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $37.00M | $19.00M | $23.00M | $26.00M | $23.00M | $27.00M | $42.00M | $53.00M | $51.00M | $50.00M | $49.00M | $56.00M | $50.00M | $41.00M | $46.00M | $57.00M | $44.00M | $46.00M | $45.00M |
| QoQ Change | — | -48.6% | +21.1% | +13.0% | -11.5% | +17.4% | +55.6% | +26.2% | -3.8% | -2.0% | -2.0% | +14.3% | -10.7% | -18.0% | +12.2% | +23.9% | -22.8% | +4.5% | -2.2% |
| YoY Change | — | — | — | -29.7% | — | +42.1% | +82.6% | +103.8% | +121.7% | +85.2% | +16.7% | +5.7% | -2.0% | -18.0% | -6.1% | +1.8% | -12.0% | +12.2% | -2.2% |